CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Bal Pharma Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Bal Pharma Ltd
Four Mangoe Lane
Surendra Mohan Ghosh Sarani
Phone: +91 8041379500p:+91 8041379500 BANGALORE, 560052  India Ticker: BALPHARMABALPHARMA
Business Summary
Bal Pharma Limited is a pharmaceutical company, which is engaged in manufacturing and selling of pharmaceutical products. The Company is engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients (API). It is specialized in prescription drugs, generic & OTC products, intravenous infusion, and bulk actives. The Company offers range of APIs includes antihistamine, platelet inhibitor, anti-diabetic, anti-convulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, acne treatment, and others. It also offers range of formulations products covering dosage forms-tablets, capsules, syrups, suspensions, IV infusions, ophthalmic, creams and ointments to various semi-regulated markets. The API products are being exported to Japan, Australia, Spain, the United Kingdom, Canada, Nigeria, Iceland, Slovenia, Romania, Brazil, Pakistan, Germany, South Africa, Serbia, Taiwan, Malaysia, Thailand, among others.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20243/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer AkashMathur 9/1/2016 9/1/2016
Compliance Officer, Company Secretary AbdulBasith 7/17/2023 7/17/2023
Managing Director, Executive Director Shailesh D.Siroya 45
3 additional Officers and Directors records available in full report.

Business Names
Business Name
524824
BALPHARMA

General Information
Outstanding Shares: 15,920,872 (As of 9/30/2024)
Shareholders: 7,815
Stock Exchange: NSE
Fax Number: +91 8022354057


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 22, 2024